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Summary
Objective: To compare the Osteoarthritis Research Society International (OARSI) response criteria for clinical trials with patient’s global as-
sessment in patients with osteoarthritis (OA) of the hip receiving a non-pharmacological intervention, i.e., manual therapy or exercise therapy.
Methods: Data of a randomized clinical trial on manual therapy and exercise therapy in patients with OA of the hip (nZ 109) were used.
Change scores of measures of hip function, range of joint motion and pain were compared between patients who were differently classiﬁed
by the OARSI response criteria and the patient’s global assessment (using a t test, 95% CI). Furthermore, risk ratios (with 95% CI) were cal-
culated for the contrast between treatment outcome, using the OARSI criteria or patient’s global assessment.
Results: Few patients were classiﬁed as improved (i.e., responders) with the OARSI response criteria as compared to patient’s global assess-
ment. Signiﬁcantly worse outcome for hip function and pain was observed in patients who were classiﬁed as non-responders (OARSI criteria),
but who considered themselves as improved (patient’s global assessment). Risk ratios for the contrast between the two treatment programs
(manual therapy vs exercise therapy) were similar, when using the OARSI criteria or patient’s global assessment.
Conclusion: The validity of the OARSI response criteria has been previously demonstrated in OA patients treated with pharmacological inter-
ventions. The present study demonstrates the validity of the OARSI response criteria in OA patients treated with a non-pharmacological
intervention, i.e., manual therapy and exercise therapy.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The Osteoarthritis Research Society International (OARSI)
proposed response criteria to deﬁne clinically relevant
change in patients participating in osteoarthritis (OA) clinical
trials1. Criteria include the domains of pain, function and pa-
tient’s global assessment. These response criteria were val-
idated using data of 14 clinical trials on the effects of
pharmacological modalities in patients with complaints
due to OA. However, OARSI recommends further validation
of these response criteria in additional data sets in other
pharmacological and non-pharmacological interventions.
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exercise therapy inpatientswithOAof thehip ina randomized
clinical trial2.Wechosepatient’sglobal assessmentona tran-
sition scale as the primary outcome. However, the use of pa-
tient’s global assessment to determine clinically relevant
change has been criticized because it may be affected by
other changes in health status and by subjective bias3e5.
The Philadelphia Panel on evidence based practice guide-
lines on selected rehabilitation interventions, recommended
to assess a cut off point of 15% improvement onmeasures of
pain, function and health status when evaluating the efﬁcacy
of treatment of physical therapy and other rehabilitation inter-
ventions in low back, neck, knee and shoulder pain clinical
trials4. However, these response criteria were not validated
with regard to sensitivity and speciﬁcity and it is not clearly
described how they should be used. Thus, to our knowledge
there are no speciﬁc response criteria available to evaluate
the efﬁcacy of physical therapy in patients with OA of the hip.7
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which were originally validated for pharmacological interven-
tions, are suitable to evaluate the clinical relevance of a
non-pharmacological intervention, i.e., manual therapy or
exercise therapy in patients with complaints due to OA of
the hip. Therefore, the goal of the present study was to com-
pare the OARSI criteria with patient’s global assessment us-
ing data of a randomized clinical trial on patients with OA of
the hip receiving manual therapy or exercise therapy.
Method
PATIENTS
Data of 109 patients with OA of the hip, participating in
a randomized clinical trial on the effects of manual therapy
were used. Results of this study were published else-
where2. Patients included were those suffering from primary
OA of the hip according to the clinical criteria of the Ameri-
can College of Rheumatology6.
Exclusion criteria were (1) symptoms in both hips, (2) age
!60 orO85 years, (3) severe complaints of the lower back,
and (4) severe cardio-pulmonary disease. All patients com-
pleted a written informed consent form. After baseline as-
sessments patients were randomly allocated to exercise
therapy or manual therapy by an independent person, using
opaque sealed envelopes. A blinded assessor performed
all assessments. The study was approved by the medical
ethics committee of the Leyenburg Hospital.
INTERVENTIONS
We made a comparison of two interventions: manual ther-
apy vs exercise therapy. Patients received treatment ac-
cording to a standardized protocol at the outpatient clinic
of physical therapy of our hospital. Manual therapy consisted
of stretching of shortened muscles and manipulation of the
hip joint 7. The exercise program was tailored to the individ-
ual patient’s needs, and consisted of both active and passive
exercises and homework exercises. The exercise program
was an adaptation of the protocol of Van Baar et al.8.
All patients were treated twice weekly for a period of 5
weeks to a total of nine treatments. The use of NSAIDs
(non steroid anti-inﬂammatory drugs) and pain medication
was allowed, under the condition that it was left unchanged
during the study period.
OUTCOME ASSESSMENT
The primary outcome measure was the patient’s global
assessment of outcome on a six-point Likert scale (ranging
from ‘much worse’ to ‘free of complaints’).
The question that was asked was: what where the effects
of treatment on your complaints? Patients who classiﬁed
themselves as ‘improved’, ‘much improved’, or ‘free of com-
plaints’ were identiﬁed as clinically relevant improved. Sec-
ondary outcome measures included hip function, range of
motion (ROM) and pain. Hip function was evaluated with
the Harris Hip Score9. The Harris Hip Score has been pri-
marily developed to evaluate hip function in patients with
hip OA. Furthermore, the Harris Hip Score showed to be
a reliable and responsive measure9. ROM was assessed
with a goniometer according to a standardized protocol10,11.
Overall scores (sum score) for ROM were obtained by cal-
culating standardized scores (Z scores) of all directions and
adding them up . Walking ability was evaluated with an
80 m walking test12,13. Furthermore, pain during the walkingtest was assessed using a visual analogue scale (VAS)13. A
blinded assessor (a physical therapist) evaluated patients at
baseline, at 5 weeks (post treatments) and at 3 and 6
months. All assessments followed a standardized proce-
dure. For the present study baseline data and post treat-
ment data (5 weeks) were used.
OARSI RESPONSE CRITERIA
The OARSI response criteria include two propositions (A
and B) (Figs. 1 and 2). As both response criteria sets gave
similar outcome, the authors proposed them both to be
used in OA trials (primarily on the efﬁcacy of NSAID), with-
out preferences for either set A or set B1. The criteria set A
(Fig. 1) ﬁrstly emphasizes the domain of pain: a high im-
provement in pain is sufﬁcient to classify a responder. A
high response on pain is deﬁned as an improvement of at
least 50% from baseline values, together with an improve-
ment of at least 20 NU (Normalized Units) on a 0e100
scale. Patients can also be classiﬁed as responders if
a moderate improvement is observed in two out of three
domains, and these domains include pain, function and
patient’s global assessment. A moderate improvement in
pain is deﬁned as an improvement of at least 30%, together
with an improvement of at least 15 NU.
A moderate improvement for function is deﬁned as an im-
provement of at least 20%, together with an improvement of
20 NU. When a VAS is applied as a patient’s global assess-
ment, an improvement of at least 20% is required.
The second set of criteria (set B) is slightly different with
regard to the deﬁnition of a high response: with this set
a high response in pain or function classiﬁes a responder.
However, the criteria for moderate improvement on pain,
function and patient’s global assessment are similar to the
criteria of set A.
STATISTICAL ANALYSIS
Firstly, OARSI deﬁned responders and patients classiﬁed
as improved by patient’s global assessment were compared
using cross tabs on all test data (exercise therapy group
and manual therapy group together). Secondly, change
scores for hip function (the Harris Hip Score, range of mo-
tion (ROM) and pain) were compared for patients who were
differently classiﬁed by patient’s global assessment and by
the OARSI response criteria. Differences between change
scores were tested using t tests (with 95% CI). Thirdly, to
High improvement in pain (50%) + 20 NU*
Yes No
Responder Moderate improvement in:
•  Pain (30%) + 15 NU
•  Function (20%) + 20 NU
•  Patient’s global assessment 
2 or 3 0 or 1
Responder Non responder
Fig. 1. OARSI response criteria proposition A.
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therapy) on the primary outcome measure ‘‘patient’s global
assessment’’ a risk ratio (OR) was calculated with a 95%
conﬁdence interval. In addition, a risk ratio (with 95% CI)
was calculated using the criteria sets A and B (Fig. 1) to
classify patients receiving manual therapy or exercise ther-
apy as responders. A two-sided alpha of 5% was applied for
signiﬁcance14. Data were analyzed using SPSS 11.0
software.
Results
PATIENTS
Baseline characteristics of patients are presented in
Table I. Mean age was relatively high (72 years). Most pa-
tients (80%) had moderate to severe OA on Kellgren and
Lawrence radiographic scores.
Furthermore, most patients indicated pain as their main
complaint (65%). In total nine patients discontinued the
treatment programs. All patients discontinued due to practi-
cal problems, such as travel distance or other health prob-
lems that cannot be related to treatment with physical
therapy or manual therapy.
OUTCOME OF MANUAL THERAPY AND EXERCISE THERAPY
The results of the randomized clinical trial indicated that
manual therapy is superior to exercise therapy in the meas-
ures of function and pain. After treatment (5 weeks) the Har-
ris Hip score improved from 54.0 (15) to 69.3 (15) in the
manual therapy group, and from 53.1 (14) to 57.2 (11) in
the exercise group (mean change score between groups:
11.2, CI: 6.1e16.3). Pain (in mm on VAS) in the manual
therapy group decreased from 34.0 (22) to 22.8 (21), while
in the exercise group pain during walking remained almost
stable (28.9 (22) to 27.1 (21); mean change score between
groups 9.6, CI: 17.3 to 1.8). Finally, ROM increased in
the manual group from 101.3( (20() to 115.8( (10(); 16.0(
(CI: 8.1e22.6() degrees more than in the exercise group.
These data have been previously reported2.
OARSI CRITERIA VS PATIENT’S GLOBAL ASSESSMENT
Table II shows cross tabs of the criteria set A vs patient’s
global assessment. Results indicate that a large number of
patients (nZ 28) were classiﬁed as improved on patient’s
High improvement in pain (50%) or function (60%) + 20 NU
Yes No
Responder
 
2 or 3 0 or 1
Responder Non responder
Moderate improvement in:
•  Pain (30%) + 20 NU
•  Function (20%) + 15 NU
•  Patient’s global assessment
Fig. 2. OARSI response criteria proposition B.global assessment, while on the other hand these patients
were classiﬁed as non-responders by the OARSI criteria.
B criteria gave similar results (data not shown). In order to
investigate possible differences in characteristics between
patients who were classiﬁed differentially by patient’s global
assessment and the OARSI criteria, we compared change
scores of hip function (Harris Hip Score), pain (VAS) and
ROM (Table III) of these patients with each other. Results
show signiﬁcant lower scores on hip function and lower
scores for improvement in pain in patients who were classi-
ﬁed as improved on patient’s global assessment but as
non-responders with the criteria set A vs patients who were
classiﬁed as improved and as responders with the OARSI
criteria A (Table III). Results of the analysis of change
scores of hip function, pain and ROM of patient’s global
assessment vs criteria set B gave similar results (data not
presented).
Finally, we investigated the relation between outcome of
the classiﬁcations (i.e., patient’s global assessment and
OARSI response criteria) and baseline characteristics
(i.e., sex, age, hip function, pain, ROM, duration of com-
plaints). However, no signiﬁcant differences were found
(data not presented).
MANUAL THERAPY VS EXERCISE THERAPY
In Table IV it is shown that 43 (81%) patients receiving
manual therapy were classiﬁed as ‘improved’ vs 25 (50%)
Table I
Baseline characteristics (nZ 109)
Manual
therapy
Exercise
therapy
Number of patients 56 53
Females/males (n) 38/18 38/15
Age in years, mean (sd) 72 (7) 71 (6)
Medication
No medication (N ) 41 38
Analgesics or NSAIDs (N ) 15 15
Radiological degeneration (N )*
0 (No OA) 5 4
1 (Mild OA) 7 6
2 (Moderate OA) 19 23
3 (Severe OA) 25 20
Main complaint (N )
Pain 34 33
Morning stiffness 5 4
Starting stiffness 4 3
Walking disability 13 14
Harris Hip score, mean (SD) 54 (15) 53 (14)
Pain during walking, mm,
mean (SD)
34 (22) 29 (22)
Range of motiony 1.6 (4.2) 1.5 (4.4)
*Modiﬁed Kellgren and Lawrence.
yZ score (sum score of separate directions).
Table II
OARSI criteria set A vs patient’s global assessment (patients
receiving manual therapy or exercise therapy combined)
Patient’s global assessment OARSI set A
Non-responder Responder
Not improved 33 2
Improved 28 40
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Comparison in mean change scores (standard deviation) of patients differentially classified by the OARSI criteria and global assessment
Improved (global ass.) and non-responder Improved (global ass.) and responder Mean difference 95% CI
N (OARSI) N (OARSI)
Harris 28 12.7 (9) 40 19.3 (13)  6.6 12.5, 0.7*
Pain 28 1.7 (20) 40 32.3 (20) 30.6 20.3, 40.5*
ROM 28 0.9 (3) 40 0.5 (3) 0.4 1.7, 2.6
*P! 0.05. On Harris Hip Score and ROM positive signs indicate improvement. On pain negative signs indicate improvement. NZ number
of patients.patients receiving exercise therapy (risk ratio 1.62, CI:
1.20e2.20). Results of the analysis with the OARSI A re-
sponse criteria showed that fewer patients were classiﬁed
as responders in each treatment group as compared to pa-
tient’s global assessment.
However, the contrast between the two treatment groups
generally remained equal (risk ratio 1.70 CI: 1.03e2.80).
Finally, criteria set B gave almost similar results as com-
pared to criteria set A (risk ratio 1.77 CI: 1.11e2.82).
Discussion
This is the ﬁrst study on the validity of the OARSI re-
sponse criteria in patients treated with a non-pharmacolog-
ical intervention, i.e., manual therapy and exercise therapy.
The OARSI response criteria were developed to evaluate
the efﬁcacy of different classes of interventions: however,
the criteria were validated for pharmacological interventions
only. We compared two methods to evaluate the success of
treatment: (A) patient’s global assessment and (B) the
OARSI response criteria. Results indicated that in patients
treated with a non-pharmacological intervention (i.e., manu-
al therapy and exercise therapy), the OARSI response is
more rigorous than the patient’s global assessment (fewer
patients were denoted as responders as compared to the
patient’s global assessment).
We examined in the group of patients who considered
themselves as improved the differences in the magnitude
of changes in measures of pain and function between res-
ponders and non-responders according to the OARSI crite-
ria. In responders a larger increase in hip function and
larger decrease in pain were observed than in the non-
responders.
Those results suggest that improvement on a single tran-
sition measure is not accompanied by improvements in
Table IV
Patient’s global assessment vs OARSI criteria: risk ratio for
improvement/responder of manual therapy vs exercise therapy
Manual
therapy
Exercise
therapy
Risk
ratio
95%
CI
Patient’s global assessment
Improved 43 25 1.62 1.20e2.20
Not improved 10 25
Criteria set A
Responder 27 15 1.70 1.03e2.80
Non-responder 26 35
Criteria set B
Responder 30 16 1.77 1.11e2.82
Non-responder 23 34measures of hip and function in all patients. In the OARSI
response criteria the outcomes of several measures are
combined, thus increasing the likelihood of detecting pa-
tients with a clinically relevant improvement.
Response criteria were primarily suggested to be used as
evaluation measures in clinical trials1. However, response
criteria are also valuable in clinical settings. In clinical prac-
tice a patient’s global assessment or a single clinical test is
often used to determine change in clinical status. A patient’s
global assessment is an easy to use tool, but it has been
criticized for its sensitivity to be affected by other changes
in health status10. Clinical tests give an ‘‘objective’’ (obser-
vational) judgment on the clinical status of patients but do
not incorporate the patient’s perspective. The OARSI crite-
ria incorporate both reported scores and observations by
a physician or physical therapist. Furthermore, cut off points
for response criteria are constructed by consensus or by
validation on data of speciﬁed studies, which makes re-
sponse criteria more widely applicable. Therefore, we rec-
ommend assessing response criteria in both research and
clinical settings.
A possible limitation of our study could be that we used
a transition scale for global assessment. In the OARSI re-
sponse criteria the use of a VAS is described with a cut off
point of 20%, for clinically relevant improvement. Instead,
we used a six-point scale ranging from ‘much worse’ to ‘free
of complaints’. The fourth step in this scale is deﬁned as ‘im-
proved’; therefore we used this as a cut off point for clini-
cally relevant improvement. We believe that these cut off
points are comparable, as they both represent moderate im-
provement in health status.
In conclusion, we found the OARSI response criteria suit-
able to evaluate the outcome of a non-pharmacological
treatment, i.e., manual therapy and exercise therapy, in pa-
tients with OA of the hip. Evidence was obtained that the
OARSI response criteria gave a more accurate reﬂection
of the actual clinical status of patients than a patient’s global
assessment of response to treatment alone.
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